Study of the Chemical Composition and Anti-Inflammatory Mechanism of Shiyiwei Golden Pill Based on UPLC-Q-TOF/MS and Network Pharmacology
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s505880 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Cong Han und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan, Shandong, People's Republic of China. Hauptthemen laut MEDLINE: Network Pharmacology, Drugs, Chinese Herbal, Anti-Inflammatory Agents, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan, Shandong, People's Republic of China.
- Department of Tibetan Medicine, Tibetan Traditional Medicine College, Lhasa, Tibet, People's Republic of China.
- Shandong Academy of Chinese Medicine, Jinan, Shandong, People's Republic of China.
Zitieren
APA
Han, C., Chen, J., Shen, C., Liang, Q., An, Y., Zhou, C., Liu, K., Xia, Q., He, Q., & Zhang, H. (2025). Study of the Chemical Composition and Anti-Inflammatory Mechanism of Shiyiwei Golden Pill Based on UPLC-Q-TOF/MS and Network Pharmacology. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s505880
Vancouver
Han C, Chen J, Shen C, Liang Q, An Y, Zhou C, et al. Study of the Chemical Composition and Anti-Inflammatory Mechanism of Shiyiwei Golden Pill Based on UPLC-Q-TOF/MS and Network Pharmacology. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s505880
BibTeX
@article{Han2025,
author = {Han, Cong and Chen, Jing and Shen, Chuanlin and Liang, Qiuxia and An, Ying and Zhou, Chaoyi and Liu, Kechun and Xia, Qing and He, Qiuxia and Zhang, Huazheng},
title = {Study of the Chemical Composition and Anti-Inflammatory Mechanism of Shiyiwei Golden Pill Based on UPLC-Q-TOF/MS and Network Pharmacology},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s505880}
}
EUVIMED